Anthony DiMeo

Investor Relations Contact at AMNEAL PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Anthony DiMeo is currently working as the Head of Investor Relations at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. He completed his undergraduate degree from The University at Buffalo School of Management.

Anthony DiMeo active positions

Companies	Position	Start
AMNEAL PHARMACEUTICALS, INC.	Investor Relations Contact	2021-03-31
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Investor Relations Contact	2021-03-31

All active positions of Anthony DiMeo

Training of Anthony DiMeo

The University At Buffalo School of Management

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anthony DiMeo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AMNEAL PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Health Technology